Science and research
National research projects
Systematic support of non-commercial clinical research in the Czech Republic. From project initiation through methodological and regulatory support to their implementation in clinical practice.
Characteristics of national research projects
CZECRIN participates in the implementation of non-commercial clinical trials and related research activities focused on the current needs of the Czech healthcare system within national research projects. These projects are developed in collaboration with teaching hospitals, research institutions and other professional workplaces in the Czech Republic and are implemented in accordance with national and international clinical research standards.
National research projects are a key tool for developing clinical and translational research, generating independent evidence-based data and translating research findings into clinical practice. CZECRIN applies its expertise, methodological and infrastructural capacities in these projects to support the development of new diagnostic and therapeutic procedures and to contribute to the improvement of healthcare in the Czech Republic.
SFZ LIPIDICA
LIPIDICA_01-2024 FUNCTIONAL SUITABILITY STUDY Pancreatic cancer is the 10th most common type of...
CT INFURO
CLINICAL TRIAL OF INFURO INFURO is designed as a monocentric, prospective, randomized,...
KH STAGE
CLINICAL TRIAL ETAPA ETAPA is a randomized, placebo-controlled trial of early targeted treatment...
CT M.A.R.S.
CLINICAL TRIAL M.A.R.S. M.A.R.S. is a randomised double-blind placebo-controlled multicentre study...
CT MSC-EB
CLINICAL TRIAL MSC-EB Safety and efficacy of allogeneic adipose-derived mesenchymal stromal cells...
CT KDO_DC1311
CLINICAL TRIAL WHO_DC1311 Combination anti-tumour therapy with ex vivo manipulated interleukin-12...
The selected projects represent only a part of the research activities implemented within the framework of the CZECRIN national research projects.
Key National Project: clinical trials of medicinal products (CtMP)
The Clinical Trials of Medicinal Products (CTP) project is an overarching national initiative of the Ministry of Health of the Czech Republic aimed at systematic development of the clinical trial environment. The project encompasses a set of measures in the areas of infrastructure, coordination, regulation, data handling and international cooperation with the aim of increasing the attractiveness and competitiveness of the Czech Republic in the field of clinical research.
The role of CZECRIN in the KHLP project
CZECRIN is involved in the implementation of the KHLP project across its thematic areas and working groups, playing a particularly important role in the coordination and communication of the project. This is carried out under the name Czech Republic for Clinical Research, which serves as a unified presentation and information platform of the project towards the professional public, foreign sponsors and other partners.
Why KHLP is a key national project
The Clinical Trials of Medicinal Products (CTMP) project is a key national framework for the development of the clinical trials environment in the Czech Republic. It responds to the long-standing need for a systematic, coordinated and transparent approach to clinical research that links professional capacity, infrastructure and regulatory environment into a functional whole.
The importance of the project lies in its ability to unify previously fragmented activities and to create a common platform for collaboration between public administration, research infrastructures, academia, healthcare institutions, industry and patient organisations. The KHLP is thus not a single initiative but a long-term strategic approach that promotes stability, predictability and credibility of the clinical trials system.
At the same time, the project strengthens the international competitiveness of the Czech Republic in the field of clinical research and contributes to better accessibility of innovative treatments for patients. By linking professional, organisational and communication activities, KHLP creates conditions for sustainable development of clinical trials with a real impact on healthcare.